190 related articles for article (PubMed ID: 33461213)
1. MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data.
Han X; Zhang S; Zhou DC; Wang D; He X; Yuan D; Li R; He J; Duan X; Wendl MC; Ding L; Niu B
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33461213
[TBL] [Abstract][Full Text] [Related]
2. MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability.
Jia P; Yang X; Guo L; Liu B; Lin J; Liang H; Sun J; Zhang C; Ye K
Genomics Proteomics Bioinformatics; 2020 Feb; 18(1):65-71. PubMed ID: 32171661
[TBL] [Abstract][Full Text] [Related]
3. Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.
Willis J; Lefterova MI; Artyomenko A; Kasi PM; Nakamura Y; Mody K; Catenacci DVT; Fakih M; Barbacioru C; Zhao J; Sikora M; Fairclough SR; Lee H; Kim KM; Kim ST; Kim J; Gavino D; Benavides M; Peled N; Nguyen T; Cusnir M; Eskander RN; Azzi G; Yoshino T; Banks KC; Raymond VM; Lanman RB; Chudova DI; Talasaz A; Kopetz S; Lee J; Odegaard JI
Clin Cancer Res; 2019 Dec; 25(23):7035-7045. PubMed ID: 31383735
[TBL] [Abstract][Full Text] [Related]
4. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL
BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937
[TBL] [Abstract][Full Text] [Related]
5. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data.
Niu B; Ye K; Zhang Q; Lu C; Xie M; McLellan MD; Wendl MC; Ding L
Bioinformatics; 2014 Apr; 30(7):1015-6. PubMed ID: 24371154
[TBL] [Abstract][Full Text] [Related]
6. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
[TBL] [Abstract][Full Text] [Related]
7. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS.
Kautto EA; Bonneville R; Miya J; Yu L; Krook MA; Reeser JW; Roychowdhury S
Oncotarget; 2017 Jan; 8(5):7452-7463. PubMed ID: 27980218
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Al Zoughbi W; Fox J; Beg S; Papp E; Hissong E; Ohara K; Keefer L; Sigouros M; Kane T; Bockelman D; Nichol D; Patchell E; Bareja R; Karandikar A; Alnajar H; Cerqueira G; Guthrie VB; Verner E; Manohar J; Greco N; Wilkes D; Tagawa S; Malbari MS; Holcomb K; Eng KW; Shah M; Altorki NK; Sboner A; Nanus D; Faltas B; Sternberg CN; Simmons J; Houvras Y; Molina AM; Angiuoli S; Elemento O; Mosquera JM
Oncologist; 2021 Nov; 26(11):e1971-e1981. PubMed ID: 34286887
[TBL] [Abstract][Full Text] [Related]
9. Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing.
Cai Z; Wang Z; Liu C; Shi D; Li D; Zheng M; Han-Zhang H; Lizaso A; Xiang J; Lv J; Wu W; Zhang Z; Zhang Z; Yuan F; He S; Sun J
J Mol Diagn; 2020 Jul; 22(7):860-870. PubMed ID: 32428677
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade.
Georgiadis A; Durham JN; Keefer LA; Bartlett BR; Zielonka M; Murphy D; White JR; Lu S; Verner EL; Ruan F; Riley D; Anders RA; Gedvilaite E; Angiuoli S; Jones S; Velculescu VE; Le DT; Diaz LA; Sausen M
Clin Cancer Res; 2019 Dec; 25(23):7024-7034. PubMed ID: 31506389
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis for Cell-Free Tumor DNA Sequencing Data.
Chen S; Liu M; Zhou Y
Methods Mol Biol; 2018; 1754():67-95. PubMed ID: 29536438
[TBL] [Abstract][Full Text] [Related]
12. Clinical predominance of whole-exome sequencing to evaluate microsatellite instability status.
Takamatsu R; Nakamura K; Suzuki O; Okada C; Mori R; Kawano R; Hayashi H; Ishikawa M; Aimono E; Nohara S; Tanishima S; Ueki A; Ishida H; Nishihara H
Cancer Sci; 2023 Jul; 114(7):2848-2859. PubMed ID: 37119014
[TBL] [Abstract][Full Text] [Related]
13. Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing.
Bonneville R; Krook MA; Chen HZ; Smith A; Samorodnitsky E; Wing MR; Reeser JW; Roychowdhury S
Methods Mol Biol; 2020; 2055():119-132. PubMed ID: 31502149
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Microsatellite Instability from Next-Generation Sequencing Data.
Renault V; Tubacher E; How-Kit A
Adv Exp Med Biol; 2022; 1361():75-100. PubMed ID: 35230684
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability detection in breast cancer using drop-off droplet digital PCR.
Klouch KZ; Stern MH; Trabelsi-Grati O; Kiavue N; Cabel L; Silveira AB; Hego C; Rampanou A; Popova T; Bataillon G; Nasr S; Proudhon C; Michel M; Renault V; Masliah Planchon J; Vincent-Salomon A; Pierga JY; Bieche I; Renault S; Bidard FC
Oncogene; 2022 Dec; 41(49):5289-5297. PubMed ID: 36329125
[TBL] [Abstract][Full Text] [Related]
16. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
[TBL] [Abstract][Full Text] [Related]
17. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Razavi P; Li BT; Brown DN; Jung B; Hubbell E; Shen R; Abida W; Juluru K; De Bruijn I; Hou C; Venn O; Lim R; Anand A; Maddala T; Gnerre S; Vijaya Satya R; Liu Q; Shen L; Eattock N; Yue J; Blocker AW; Lee M; Sehnert A; Xu H; Hall MP; Santiago-Zayas A; Novotny WF; Isbell JM; Rusch VW; Plitas G; Heerdt AS; Ladanyi M; Hyman DM; Jones DR; Morrow M; Riely GJ; Scher HI; Rudin CM; Robson ME; Diaz LA; Solit DB; Aravanis AM; Reis-Filho JS
Nat Med; 2019 Dec; 25(12):1928-1937. PubMed ID: 31768066
[TBL] [Abstract][Full Text] [Related]
18. DeltaMSI: artificial intelligence-based modeling of microsatellite instability scoring on next-generation sequencing data.
Swaerts K; Dedeurwaerdere F; De Smet D; De Jaeger P; Martens GA
BMC Bioinformatics; 2023 Mar; 24(1):73. PubMed ID: 36859168
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types.
Hirotsu Y; Nagakubo Y; Amemiya K; Oyama T; Mochizuki H; Omata M
Clin Chim Acta; 2020 Mar; 502():207-213. PubMed ID: 31730810
[TBL] [Abstract][Full Text] [Related]
20. Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA.
Gao M; Callari M; Beddowes E; Sammut SJ; Grzelak M; Biggs H; Jones L; Boumertit A; Linn SC; Cortes J; Oliveira M; Baird R; Chin SF; Caldas C
Genome Med; 2019 Jan; 11(1):1. PubMed ID: 30609936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
